About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Pennsylvania | 414 Studies

Clinical Trials Pancreatic CancerPennsylvania

Pancreatic Cancer Clinical Trials in Pennsylvania

Find 414 clinical trials for pancreatic cancer near Pennsylvania. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Pennsylvania

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 414 trials

TerminatedA Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid TumorsThis Phase 1b/2 study will examine the effects of the study drugs, avelumab, binimetinib and talazoparib when given in a 2 (doublet) or 3 (triplet) drug combination, in patients…NCT03637491·Fayetteville, Arkansas and 17 others Active not recruitingStudy Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With PembrolizumabThis Phase 1/2, first-in-human, open-label, multicenter study follows a 3+3 ascending dose escalation design to determine the MTD/RP2D and to characterize the safety…NCT04130516·Los Angeles, California and 9 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingIntra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCThe study is a multi-center, open-label, randomized active controlled study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.NCT03257033·Loma Linda, California and 30 others

CompletedA Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid TumorsThe study consists of 2 parts.NCT04247126·Gilbert, Arizona and 15 others

RecruitingLOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer CachexiaThis study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic…NCT06073431·Fort Smith, Arkansas and 224 others

CompletedErlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerThis is a phase 1b study to evaluate the combination of gemcitabine and Tarceva (erlotinib) and nab-paclitaxel in patients with advanced pancreatic cancer.NCT01010945·Palm Springs, California and 4 others

CompletedPhase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid TumorsThe purpose of this study is to determine the maximum dose of LDE225 and BKM120 that can be safely given together to patients and/or the dose that will be used in future studies.NCT01576666·Los Angeles, California and 22 others

CompletedVaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic CancerRATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells.NCT00008099·Pittsburgh, Pennsylvania

TerminatedA Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic CancerThe main purpose of this study is to look at the potential effects of paricalcitol (a drug similar to vitamin D) and nivolumab on pancreatic tumors in patients who are treated…NCT03519308·Philadelphia, Pennsylvania

CompletedAPRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic CancerThis study will compare the anti-tumor efficacy of apricoxib and gemcitabine/erlotinib with placebo and gemcitabine/erlotinib in patients with advanced pancreatic cancer.NCT00709826·Tucson, Arizona and 38 others

CompletedR115777 in Treating Patients Who Have Metastatic Pancreatic CancerPhase II trial to study the effectiveness of R115777 in treating patients who have metastatic pancreatic cancer.NCT00005843·Philadelphia, Pennsylvania and 1 other

CompletedSafety and Exploratory Efficacy of Kanglaite Injection in Pancreatic CancerGemcitabine is usually used to treat cancer of the pancreas.NCT00733850·Muscle Shoals, Alabama and 41 others

CompletedBPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer PatientsThis is a Phase 2 multicenter, open-label, non-randomized study to examine the safety and effectiveness of BPM31510 administered over 144-hours (two 72-hour 110mg/Kg doses)…NCT02650804·Gilbert, Arizona and 11 others

CompletedStudy of Gemcitabine, Abraxane® Plus Placebo Versus Gemcitabine, Abraxane® Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With 1st-Line Metastatic Pancreatic Ductal AdenocarcinomaThis is a randomized, double blind, 3 arm (1:1:1) study in subjects with 1st-line metastatic pancreatic ductal adenocarcinoma.NCT02289898·Gilbert, Arizona and 41 others

CompletedDetermine Function of Antroquinonol in Combination With SOC in First Line Metastatic Pancreatic CancerAntroquinonol is proposed for the treatment of neoplasms.NCT03310632·Tampa, Florida and 10 others

RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 130 others

Active not recruitingPhase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid TumorsThis is a nonrandomized, uncontrolled, open-label, multicenter Phase 2 study to evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1…NCT05945823·Santa Monica, California and 21 others

TerminatedTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsThis is a subprotocol of Master Protocol DAY101-102 and is a Phase 1b/2, multi-center, open label subprotocol of participants ≥12 years of age, with recurrent or progressive solid…NCT07121829·Los Angeles, California and 9 others

CompletedA Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.A study to collect survival data on patients previously enrolled in Abraxane pancreatic cancer study CA046.NCT02021500·Scottsdale, Arizona and 38 others

TerminatedIn Vivo PARP-1 Expression With 18F-FTT PET/CT in Pancreatic CancerThe investigators plan to enroll 30 evaluable patients with (1) a histological diagnosis of advanced pancreatic ductal adenocarcinoma who have demonstrated at least stable disease…NCT03492164·Philadelphia, Pennsylvania

PreviousPage 5 of 21Next

Other Conditions in Pennsylvania

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia